Evidence map›Paper›PMID 41749917›Full record

ArticleCancers2026

Antigen-Specific Ganglioside Serological Profile of Pancreatic and Gastric Cancer Patients by Multiple TLC Overlay Assay and IR-MALDI Mass Spectrometry.

Jamal Souady, Stephan Kirsch, Marcel Hülsewig, Romana Masnikosa, Huong Giang Vo, Jasna Peter-Katalinić, Laura Bindila

Abstract read
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jamal SouadyQIAGEN GmbH, 40724 Hilden, Germany.
Stephan KirschInstitute of Medical Physics and Biophysics, University of Münster, D-48149 Münster, Germany.
Marcel HülsewigInstitute of Medical Physics and Biophysics, University of Münster, D-48149 Münster, Germany.
Romana MasnikosaDepartment of Physical Chemistry, Institute of Nuclear Sciences Vinca, University of Belgrade, Mike Petrovica Alasa 12-14, 11000 Belgrade, Serbia.ORCID 0000-0002-5220-4334
Huong Giang VoClinical Lipidomics Unit, Institute of Physiological Chemistry, University Medical Center Mainz, D-55128 Mainz, Germany.ORCID 0009-0002-2025-6313
Jasna Peter-KatalinićInstitute of Medical Physics and Biophysics, University of Münster, D-48149 Münster, Germany.
Laura BindilaClinical Lipidomics Unit, Institute of Physiological Chemistry, University Medical Center Mainz, D-55128 Mainz, Germany.ORCID 0000-0001-5538-2008

Funding

Bundesministerium für Forschung, Technologie und Raumfahrt 03ZU1202EBEuropean Commission, Seventh Framework Programme LSHB-CT-2006-037661Ministry of Science, Technological Development and Innovation of the Republic of Serbia 451-03-66/2024-03/200017
6 · The paper itself

Abstract

backgroundAltered glycosphingolipidome in cancerous tissues and cells reflects the circulatory glycosphingolipid (GSL) profiles, which is advantageous for establishing cancer biomarkers and/or unravelling GSL-associated mechanisms of immunity in cancer.

methodsHere, we combined a microscale extraction of GSLs with multiple overlay TLC assays and IR-MALDI-o-TOF MS and implemented it for the first time in serum analysis of CD75s-, CD15s-, and iso-CD75s-containing sialylated GSLs of ganglio- and neolacto-series.

resultsThis sensitive antigen-specific targeted GSL workflow enabled the identification of 80 sialylated GSLs containing the specific antigens in human sera and was applied for the investigation of clinical serum samples from gastric/stomach cancer patients (

conclusionsThis drop suggesting a role of these highly polar complex ganglioside species in evading humoral tumor immune response in the early tumor stages.

Indexed as

cancer glycolipidsCD15sgangliosidesglycan antigensglycolipidsiso-CD75slipidomicsneolactoTLC-MS

Identifiers

PMID41749917
PMCPMC12939675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.